Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Jeff Zacharias

Jeff Zacharias

New Hope Recovery Center, USA

Frank Galimidi

Frank Galimidi

New Beginnings Recovery Center, USA

Konstantin Slavin

Konstantin Slavin

University of Illinois , USA

Durodami Lisk

Durodami Lisk

Ministry of Health USA

Peter Kaplan

Peter Kaplan

Johns Hopkins University USA

Hemanth Rao

Hemanth Rao

The Neurological Institute, USA

Lucia M. Vaina

Lucia M. Vaina

Boston University College of Engineering, USA

Jennifer DeFeo

Jennifer DeFeo

Chicago School of Psychology, USA

European Dementia 2018

About Conference


It’s with great pleasure and great honor to invite you to the “12th World Congress on Dementia and Alzheimer Rehabilitation” scheduled during November 27-29, 2018 at Athens, Greece.

Welcome to most exciting and fascinating city, Athens, Greece

Within this splendid setting, we plan to deliver a conference that will exceed your expectations. Our event aims to make people with dementia feel safe and to create a familiar environment for them.

During this year’s Conference, we hope that you will seize the opportunity to rekindle on-going connections and spark new ones with your colleagues from around the globe

The Conference will be organized around the theme “Innovative Approaches To Support: Dementia & Alzheimer Rehabilitation

European dementia 2018 anticipates more than 500 participants around the globe to experience thought provoking Keynote lectures, Oral & Poster presentations. This year conference will offer ample opportunities for all stakeholders working on Dementia, Alzheimer’s and neurology to expose their research work.

Our conference aims to gather the Researchers, principal investigators, experts, neurologists and researchers working on brain from both academia and health care industry, Business Delegates, Scientists and students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences.

This year’s Conference program, coupled with the Business Opportunity Exchange, is an event you can’t afford to miss!

Why to attend?

 12th World Congress on Dementia and Rehabilitation is organizing an outstanding Scientific Exhibition/Program and anticipates the world's leading Neurologists, health professionals involved in the profession and practice of neuroscience. The event will also reflect interest of specialists in the clinical research on dementia and Alzheimer’s disease. Conference series organizing this international event for people to take part and gain a better understanding of such diseases, to access treatment as well as information, advice and support and to have their health monitored more closely.

This International meeting is an effort to make possible interactions among world leading scientists, research scholars, professionals, young researchers from different parts of the world to exchange their knowledge and conduct symposia, show experiments with new innovative techniques that disseminate information about clinical tradition, best practices, skills and knowledge in the field of neuroscience. In Dementia and Rehabilitation 2018, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Dementia and Neurology.

Target Audience:

  • Neurologists and Directors
  • Physicians
  • Neuroscientists
  • Specialists
  • Researchers
  • Health care professionals
  • Professors
  • Industrial Experts
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Scientists
  • Lecturers and Students from Academia in the study of Dementia
  • Students from Academia in the research of Neurology
  • Neuro Physiotherapists

Sessions/Tracks

Dementia and Rehabilitation describes a set of symptoms include memory loss and difficulties with thinking or reasoning that reduce a person ability to perform everyday activities. Dementia is mainly caused when the brain is damaged by diseases, such as Alzheimer’s disease or a series of strokes. This disease mainly affects people over the age of 65 and the likelihood of developing dementia increases significantly with age. However, dementia can affect younger people too.

The conference scientific Tracks on:

Track 1: Dementia

Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease. Vascular dementia, which occurs after a stroke, is the second most common dementia type. But there are many other conditions that can cause symptoms of dementia, including some that are reversible, such as thyroid problems and vitamin deficiencies. Dementia is a syndrome that involves severe loss of cognitive abilities as a result of disease or injury. Dementia caused by traumatic brain injury is often static, whereas dementia caused by neurodegenerative disorders, such as Alzheimer's disease, is usually progressive and can eventually be fatal. Dementia can be grouped based on the part of brain being affected. it is roughly true that the earliest symptoms in "cortical" dementia include difficulty with high-level behaviors such as memory, language, problem-solving and reasoning; these functions tend to be less impaired in "subcortical" dementia.  Cortical dementia occurs because of damage in the cerebral cortex, the outer layer of the brain. They play a critical role in memory and language. The symptoms usually include severe memory loss. Alzheimer's and Creutzfeldt-Jakob disease are two forms of cortical dementia. Subcortical dementia occurs due to the damage to the part of the brain beneath the cortex. The person suffering from it can show changes in their speed of thinking. Usually, people with subcortical dementia don't have forgetfulness and language problems. Parkinson's diseaseHuntington's disease, and HIV are two forms subcortical dementia.

 1:Dementia with Lewy Bodies

 2:Mixed dementia.

 3:Frontotemporal dementia.

 4:Normal pressure hydrocephalus

 5:Signs and symptoms of dementia

Related Societies

Alzheimer's Association and Alzheimer's Foundation of America ; Lewy Body Dementia Association ; Parkinson Society CanadaAmerican Association of Neurological Surgeons ; American Academy of Neurology , World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology

Track 2: Alzheimer’s Disease

Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases. Alzheimer's is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Alzheimer's disease accounts for 60 to 80 percent of dementia cases. Alzheimer's is not a normal part of aging. The greatest known risk factor is increasing age, and the majority of people with Alzheimer's are 65 and older. But Alzheimer's is not just a disease of old age. Approximately 210,000 Americans under the age of 65 have younger-onset Alzheimer’s disease also known as early-onset Alzheimer’s.

 1:Risk Factors of alzheimers

 2:Diagnosis of alzheimers

 3:Treatments of alzheimers

 4:Clinical Studies of alzheimers

 5:Alzheimer’s disease Pathophysiology and Disease Mechanisms

Related Societies

Dementia Society of AmericaAlzheimer's Disease International (ADI), Acoustic Neuroma Association, Aicardi Syndrome Foundation and Alliance for Aging ResearchAlzheimer's AssociationAlzheimer’s and Related Disorders Society of IndiaALS Association and ALS Therapy Development InstituteAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery Foundation

Track 3: Dementia  and Ageing

Aging: Not being able to remember details of a conversation or event that took place a year ago, Not being able to remember the name of an acquaintance, Forgetting things and events occasionally, Occasionally have difficulty finding words, You are worried about your memory but your relatives are not..

Dementia: Not being able to recall details of recent events or conversations, Not recognizing or knowing the names of family members, Forgetting things or events more frequently, Frequent pauses and substitutions when finding words, Your relatives are worried about your memory, but you are not aware of any problems   

 1:Neuro-anatomical changes in ageing

 2:Risk factors of cognitive decline

 3:Granulovacuolar degeneration

 4:Changes in cerebral cortical microvasculature

 5:Advances of research in ageing and dementia

Related Societies

Alzheimer's Association and Alzheimer's Foundation of America ; Lewy Body Dementia Association ; Parkinson Society CanadaAmerican Association of Neurological Surgeons ; American Academy of Neurology , World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology

Track 4: Vascular Dementia

Vascular dementia occurs when vessels that supply blood to the brain become blocked or narrowed. Strokes take place when the supply of blood carrying oxygen to the brain is suddenly cut off. However, not all people with stroke will develop vascular dementia.

Vascular dementia can occur over time as "silent" strokes pile up. Quite often, vascular dementia draws attention to itself only when the impact of so many strokes adds up to significant disability. Avoiding and controlling risk factors such as diabetes, high blood pressure, smoking, and high cholesterol can help curb the risk of vascular dementia.

 1:Vascular dementia prognosis

 2:Young onset dementia

 3:Multi-infarct dementia

 4:Mixed dementia

 5:Parkinson dementia

 6:Advences in vascular dementia therapy

Related Societies

Dementia Society of AmericaAlzheimer's Disease International (ADI), Acoustic Neuroma Association, Aicardi Syndrome Foundation and Alliance for Aging ResearchAlzheimer's AssociationAlzheimer’s and Related Disorders Society of IndiaALS Association and ALS Therapy Development InstituteAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery Foundation

Track 5: Geriatrics Dementia and Cognitive Disorders

Geriatrics or geriatric medication may be a specialty that focuses on health care of older people. It aims to push health by preventing and treating diseases and disabilities in older adults. there's no set age at that patients are also underneath the care of a specialist or geriatric .United Nations agency makes a specialty of the care of older people. Rather, this call is set by the individual patient’s needs, and therefore the availableness of a specialist. It’s vital to notice the distinction between gerontology, the care of aged people, and geriatrics, that is that the study of the aging method itself. Cognitive disorders square measure a class of mental state disorders that primarily influenc learning,memory, perception, and drawback determination, and embody blackout, dementia, and delirium. Whereas anxiety disorders, mood disorders, and psychotic disorders can even have an effect on psychological feature and memory functions, the DSM-IV-TR doesn't contemplate these psychological feature disorders, because loss of cognitive function is not the primary causal symptom

 1:Delirium

 2:Mild and Major Neurocognitive Disorder

Related Societies

Alzheimer's Association and Alzheimer's Foundation of America ; Lewy Body Dementia Association ; Parkinson Society CanadaAmerican Association of Neurological Surgeons ; American Academy of Neurology , World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology

Track 6: Animal Models in Dementia

The animal models of dementia  and Alzheimer's disease for pre-clinical testing and clinical translation. Dementia is a clinical syndrome with abnormal degree of memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease.

 1:Neurobehavioral Toxicology Testing

 2:pre-clinical testing and clinical translation

 3:Protein-protein interactions

 4:Genetics of translational models

 5:Animal models of human cognitive aging

Related Societies

Alzheimer's Association and Alzheimer's Foundation of America ; Lewy Body Dementia Association ; Parkinson Society CanadaAmerican Association of Neurological Surgeons ; American Academy of Neurology , World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology

Track 7: Amyloid Protein in Alzheimer’s and Dementia

Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-associated protein tau.

 1:Amyloid Imaging

 2:FDG-PET

 3:Amyloid Immunotherapy

Related Societies

Dementia Society of AmericaAlzheimer's Disease International (ADI), Acoustic Neuroma Association, Aicardi Syndrome Foundation and Alliance for Aging ResearchAlzheimer's AssociationAlzheimer’s and Related Disorders Society of IndiaALS Association and ALS Therapy Development InstituteAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery Foundation

Track 8: Amyloid Imaging in Dementia

The AIT(Amyloid Imaging Task Force) concluded that amyloid imaging could potentially be helpful in the diagnosis of people with cognitive impairment when considered along with other clinical information, and when performed according to standardized protocols by trained staff. In addition, they emphasized that the decision whether or not to order amyloid imaging should be made only after a comprehensive evaluation by a physician experienced in the assessment and diagnosis of cognitive impairment and dementia, and only if the presence or absence of amyloid .

Related Societies

Alzheimer's Association and Alzheimer's Foundation of America ; Lewy Body Dementia Association ; Parkinson Society CanadaAmerican Association of Neurological Surgeons ; American Academy of Neurology , World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology

Track 9: Neurodegenerative Diseases

Degenerative nerve diseases affect many of your body's activities, such as balance, movement, talking, breathing, and heart function. Many of these diseases are genetic. Sometimes the cause is a medical condition such as alcoholism, a tumor, or a stroke. Other causes may include toxins, chemicals, and viruses. Sometimes the cause is not known.

 1:Brain diseases

 2:Traumatic brain injury

 3:Amyotrophic lateral sclerosis

 4:Spinal muscular atrophy

 5:Migraine

 6:Stroke

Related Societies

Alzheimer's Association and Alzheimer's Foundation of America ; Lewy Body Dementia Association ; Parkinson Society CanadaAmerican Association of Neurological Surgeons ; American Academy of Neurology , World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology

 Track 10: Parkinson’s Disease with Dementia

Parkinson's disease (PD) is a type of movement disorder. It happens when nerve cells in the brain don't produce enough of a brain chemical called dopamine. Sometimes it is genetic, but most cases do not seem to run in families. Exposure to chemicals in the environment might play a role. Parkinson’s Disease usually begins around age 60, but it can start earlier. It is more common in men than in women. There is no cure for Parkinson’s Disease. A variety of medicines sometimes help symptoms dramatically. Surgery and deep brain stimulation (DBS) can help severe cases. With DBS, electrodes are surgically implanted in the brain. They send electrical pulses to stimulate the parts of the brain that control movement

 1:Huntington’s Disease

 2:Anxiety`

 3:Muffled speech

Related Societies

Alzheimer's Association and Alzheimer's Foundation of America ; Lewy Body Dementia Association ; Parkinson Society CanadaAmerican Association of Neurological Surgeons ; American Academy of Neurology , World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology

Track 11: Dementia Care Management

The developing number of vascular dementia patients prompts both approach, monetary and wellbeing association imperatives. Numerous social insurance frameworks have created case administration programs with a specific end goal to advance dementia patients and guardians care and administrations conveyance.

 1:Advances in dementia care management

 2:Dementia care management program

 3:Undernutrition and obesity in dementia

 4:Advance care planning

Related Societies

Dementia Society of AmericaAlzheimer's Disease International (ADI), Acoustic Neuroma Association, Aicardi Syndrome Foundation and Alliance for Aging ResearchAlzheimer's AssociationAlzheimer’s and Related Disorders Society of IndiaALS Association and ALS Therapy Development InstituteAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery Foundation

Track 12: Dementia Nursing

People with vascular dementia have different mental element shortfalls that incorporate every memory hindrance, that influences the adaptability to discover new data or review data already learned, and one or extra of the ensuing side effects aphasiaapraxiaagnosia, or official brokenness to such an extent that the mental element shortages adversely affect social or action working with a major decrease in past abilities. Furthermore, people with dementia commonly experience the ill effects of comorbid conditions that extra confuse mind and block best results. Along these lines, creating caregiving techniques individuals with vascular dementia is pressing, given this expanding commonness and consequently the related weight that dementia places not just on the people, however on the parental figures, relations, and thusly the assets of the human services framework. Traditional perspectives bearing on geriatric nursing ordinarily paint a picture of the care as being moderate paced certain and less requesting than intense care. Be that as it may, care of the maturedand especially those with vascular dementia, is normally confounded, unusual, and flimsy.

 1:Dementia nursing care plan

 2:Music therapy in dementia

 3:Physiotherapy for dementia

 4:Clinical features of dementia

 5:Therapeutic interventions in dementia

Related Societies

Alzheimer's Association and Alzheimer's Foundation of America ; Lewy Body Dementia Association ; Parkinson Society CanadaAmerican Association of Neurological Surgeons ; American Academy of Neurology , World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology

Track 13: Neuropharmacology

Neuropharmacology is an extremely wide locale of science that includes numerous parts of the sensory system from single neuron control to whole ranges of the cerebrum, spinal line, and fringe nerves. To better comprehend the premise behind medication advancement, one should first see how neurons speak with each other. This article will concentrate on both behavioral and atomic neuropharmacology; the real receptors, particle channels, and neurotransmitters controlled through medication activity and how individuals with a neurological issue advantage from this medication activity.

 1:Neuroscience and neuropharmacology

 2:Neurochemical interaction

 3:Molecular neuropharmacology

 4:Behavioral neuropharmacology

 5:Advance research in neuropharmacology

Related Societies

Dementia Society of AmericaAlzheimer's Disease International (ADI), Acoustic Neuroma Association, Aicardi Syndrome Foundation and Alliance for Aging ResearchAlzheimer's AssociationAlzheimer’s and Related Disorders Society of IndiaALS Association and ALS Therapy Development InstituteAlternating Hemiplegia of Childhood Foundation and Alzheimer’s Drug Discovery Foundation

Track 14: Recent Advancement in Treatments of Dementia

Currently, there is no cure for Alzheimer's. But drug and non-drug treatments may help with both cognitive and behavioral symptoms. Researchers are looking for new treatments to alter the course of the disease and improve the quality of life for people with dementia.

 1:Medications for Memory Loss

 2:Treatments for Behavioral Changes of Alzheimer's

 3:Amyloid Immunotherapy

 4:Clinical Trials
 

Related Societies

Alzheimer's Association and Alzheimer's Foundation of America ; Lewy Body Dementia Association ; Parkinson Society CanadaAmerican Association of Neurological Surgeons ; American Academy of Neurology , World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology

Track 15: Treating Dementia

Early discovery and exact analysis are critical, as vascular dementia is at any rate halfway preventable .Ischemic changes in the cerebrum are irreversible, however the patient with vascular dementia can exhibit times of solidness or even gentle change. Since stroke is a basic piece of vascular dementia, the objective is to forestall new strokes. This is endeavored through decrease of stroke chance components, for example, hypertension, high blood lipid levels, atrial fibrillation, or diabetes mellitus. Meta-examinations have discovered that meds for hypertension are viable at counteractive action of pre-stroke dementia, which implies that hypertension treatment ought to be begun early .These drugs incorporate angiotensin changing over protein inhibitors, diuretics, calcium channel blockers, thoughtful nerve inhibitors, angiotensin II receptor opponents or adrenergic foes. Raised lipid levels, including HDL, were found to expand danger of vascular dementia. Ibuprofen is a medicine that is ordinarily recommended for counteractive action of strokes and heart assaults; it is likewise every now and again given to patients with dementia.

 1:Primary mental health care and nursing

 2:Psychopharmacological treatment

 3:Advanced drugs for dementia

 4:Cognitive behavioral therapy

 5:Family therapy in nursing

Related Societies

Alzheimer's Association and Alzheimer's Foundation of America ; Lewy Body Dementia Association ; Parkinson Society CanadaAmerican Association of Neurological Surgeons ; American Academy of Neurology , World Federation of Neurology ;Stroke Association ; Spanish Society of Neurology ; American Academy of Neurology ; Alzheimer's Disease International  ;  Association of Parkinsonism and Related Disorders  ; World Federation of Neurology

Track 16: Dementia Rehabilitation and Therapy

Novel therapeutics is a standout amongst the most energizing uses of data preparing frameworks is in diagnostics and treatment. This is not astonishing, given that illness analysis is in its center a data handling undertaking that finishes with a choice. In numerous infections, the conclusion can be performed in singular cells.

 1:Novel therapeutics technology

 2:Novel therapeutics strategies for Dementia

 3:Novel therapeutics molecule

 4:Anti-dementia drugs

 5:Novel drug target for the treatment of dementia

Market Analysis

The organizing committee is gearing up for an exciting and informative program on a variety of topics, poster presentations and various programs for participants from all over the world. Unsurpassed substantiation cure for Dementia clearly shows that the close association of families and carers in the care of their loved ones is key to improving early revealing of dementia, renewal to a healthy weight and sustaining long term wellbeing.

Dementia is a degenerative brain disease and the most common cause of Alzheimer’s. 1-2 Dementias is characterized by a decline in memory, language, problem-solving and other cognitive skills that affect a person’s ability to perform everyday activities. This decline occurs because nerve cells (neurons) in parts of the brain involved in cognitive function have been damaged or destroyed. Dementia is thought to be irreversible and it is caused by a number of small strokes or sometimes a large stroke preceded or followed by other smaller strokes. The term refers to a group of syndromes caused by different mechanisms all resulting in vascular lesions in the brain. Early detection and accurate diagnosis are important, as Dementia is at least partially preventable.

This conference will increase knowledge, provide support, assist learning and allow families and carers to seek out applicable services for their loved one and to develop the best possible home environment to support recovery from these complex and devastating diseases.

According to the latest figures, there are 200,000 people living with dementia in Greece and 410,000 family carers looking after them. Due to rising life expectancy worldwide and in Greece, this number could almost triple by 2040, making dementia one of the most important medical, social and economic future challenges in Greece

In Greece, there is no National Dementia Strategy in place. In accordance with European and global priorities, Greece started to organise and implement dementia programmes since 2006, but so far the resources have been limited. There are currently very few specialised services for people with dementia: 13 day care centres and three respite care facilities in Athens, Thessaloniki and smaller towns, which are operated by the Greek Alzheimer’s Associations with government funding.

The number of Americans surviving into their 80s, 90s and beyond is expected to grow dramatically due to medical advances, as well as social and environmental conditions. . By 2030, the segment of the U.S. population age 65 and older will increase substantially, and the projected 74 million older Americans will make up over 20 percent of the total population suffer from Alzheimer’s disease.

Research directed by the Alzheimer’s Society, shows that there will be 880,000 individuals living with Dementia in the UK by 2015. This will cost the UK £27 billion a year.

Dementia and Alzheimer’s  Rehabilitation 2018 will be a platform where you will be sure to have a meaningful experience with scholars from around the world. All members of the dementia and Rehabilitation 2018 organizing committee look forward to meeting you in Athens, Greece.

Past Conference Report

Dementia 2017

9th International Conference on Alzheimer’s Disease & Dementia was organized during October 16-18, 2017 at Holiday Inn Aurelia, Rome, Italy with the support and contribution of the Organizing Committee Members.

Firstly we must thank you for trusting us and participating at Dementia 2017, a global platform to discuss various important aspects of Alzheimer’s diseasekand Neurological disorders.

There are infinite reasons to extend our gratitude to you for making Dementia 2017 an outstanding conference. We couldn’t have done it without your continuous support and believe towards our organization, which mutually made to achieve Dementia 2017 a new heights in the field of Neuroscience.

The conference was marked with the attendance of young and brilliant researchers, business delegates, Exhibitors and talented student communities representing more than 15 countries, who have driven this event into the path of success.

The conference was organized around the theme “An Insight into Advanced Research and Diagnostic Approaches in Alzheimer’s Disease and Dementia”. The event implanted a firm relation of upcoming strategies in the field of Research and Developments in Dementia with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures.

The conference witnessed an amalgamation of peerless speakers, Keynote sessions, workshops, symposium well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurology, Alzheimer’s disease and Dementia through their fabulous presentations at the podium of Dementia 2017. So as a continuation of Dementia 2017, we would like to heartily invite you to our upcoming International Conference on 12th World Congress on  Dementia and Rehabilitation during Novmber 27-29, 2018 Athens Greece.

For 2018 we are expanding our focus towards all aspects of Alzheimer’s Disease & Dementia Research findings. Our organizing committee is gearing up with more innovative and explorative sessions to unleash the boundaries of the Neurology Neurological disordersAlzheimer’s Disease & Dementia. 

All accepted abstracts have been indexed in the supporting Journals as a special issue. Conference Series felicitated all the Organizing Committee Members who enthusiastically participated in the conference and made this meeting a huge success.

We would like to proudly announce “12th World Congress on Dementia and Alzheimer Rehabilitation” during November 27-29, 2018 Athens, Greece. We wish to pioneer a way to another outstanding event in the Athens, Greece


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 27-29, 2018

For Sponsors & Exhibitors

sponsors@conferenceseries.com

Speaker Opportunity

Day 1

Supported By

Journal of Alzheimers Disease & Parkinsonism Journal of Neurological Disorders Brain Disorders & Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

Collaboration

Collaboration